LifeMap Sciences, a Subsidiary of BioTime, Announces Release of LifeMap DiscoveryTM Version 1.1 with
LifeMap Sciences, a Subsidiary of BioTime, Announces Release of LifeMap DiscoveryTMVersion 1.1 with Enhanced Therapeutic Discovery and Commercial Utility According to Google Analytics, the integrated ...
LifeMap Sciences' discovery platform will be used to evaluate approximately 100 million proprietary gene expression data points relating to human embryonic stem cells generated by BioTime scientists ...
ORANGE, Calif.--(BUSINESS WIRE)--There are more than 50 million people living in modern slavery and exploitation worldwide, yet less than 1% of survivors are identified and even fewer receive the care ...
New Release Features “Super-Pathways” and Collaboration with Lost Island Labs, Inc. <0> BioTime, Inc.Peter Garcia, 510-521-3390, ext. 367Chief Financial OfficerJudith Segall, 510-521-3390, ext.
Developed by a leading bioinformatics team at the Weizmann Institute of Science, GeneCards(R) is an online database that provides concise genomic, transcriptomic, genetic, proteomic, functional and ...
A new version of MyHeartCounts, one of the original ResearchKit apps, is now available. The app, which was developed by Stanford University and BioTime subsidiary LifeMap Solutions, measures activity ...
PORTLAND, Ore., Oct. 10, 2012 /PRNewswire/ -- LifeMap Assurance Company is pleased to announce the addition or promotion of eight staff to the company's leadership team. These individuals will guide ...
“LifeMap Solutions is dedicated to building mobile health (or mHealth) apps that positively, powerfully affect patients’ quality of life,” said Corey Bridges, CEO of LifeMap Solutions. “We’ve built ...
In the first third-party post to Apple's ResearchKit blog, mobile health provider LifeMap Solutions reports seeing high rates of consent and participation due in large part to iOS and iPhone app ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results